March 17, 2014

UK announces Early Access to Medicines Scheme aimed at "breakthrough medicines"

Arnold & Porter Advisory

On 14 March 2014, the UK Government announced the Early Access to Medicines Scheme (EAMS), a voluntary and non-statutory scheme that will be launched in April 2014. The EAMS will run in parallel with the existing UK and EU licensing procedures, and is intended to allow patients to access innovative unlicensed or off-label medicines earlier than the current marketing authorisation procedures permit.

Subscribe Link

Email Disclaimer